Fact Based Investing- “ The NIH confirmed to GEN it has awarded contracts totaling $25.8 million to Leidos Biomedical Research toward managing, overseeing, and conducting the trial, the most recent being $14.3 million awarded on August 4. As for the Phase III study, it is about halfway through enrollment, and expected to finish by end of September or early October, with data expected to be released about a month later.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.